1-5 of 5
Authors: Ronza Najjar-Debbiny
Sort by
Journal Article
Effectiveness of Evusheld in Immunocompromised Patients: Propensity Score–Matched Analysis
Ronza Najjar-Debbiny and others
Clinical Infectious Diseases, Volume 76, Issue 6, 15 March 2023, Pages 1067–1073, http://doi.org/10.1093/cid/ciac855
Published: 31 October 2022
Journal Article
Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis
Ronza Najjar-Debbiny and others
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages 453–460, http://doi.org/10.1093/cid/ciac781
Published: 20 September 2022
Journal Article
Reply to Chen et al, Uchikoba et al, Siberry et al, and Vuorio et al
Ronza Najjar-Debbiny and others
Clinical Infectious Diseases, Volume 75, Issue 12, 15 December 2022, Pages 2282–2283, http://doi.org/10.1093/cid/ciac668
Published: 17 August 2022
Journal Article
Reply to Pesko et al
Ronza Najjar-Debbiny and others
Clinical Infectious Diseases, Volume 75, Issue 11, 1 December 2022, Page 2050, http://doi.org/10.1093/cid/ciac589
Published: 23 July 2022
Journal Article
Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
Ronza Najjar-Debbiny and others
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e342–e349, http://doi.org/10.1093/cid/ciac443
Published: 06 July 2022
Advertisement
Advertisement